IL141586A0 - Cyclic prosaposin-derived peptide and uses thereof - Google Patents
Cyclic prosaposin-derived peptide and uses thereofInfo
- Publication number
- IL141586A0 IL141586A0 IL14158699A IL14158699A IL141586A0 IL 141586 A0 IL141586 A0 IL 141586A0 IL 14158699 A IL14158699 A IL 14158699A IL 14158699 A IL14158699 A IL 14158699A IL 141586 A0 IL141586 A0 IL 141586A0
- Authority
- IL
- Israel
- Prior art keywords
- derived peptide
- prosaposin
- cyclic
- cyclic prosaposin
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9835998P | 1998-08-28 | 1998-08-28 | |
PCT/US1999/019378 WO2000012553A1 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141586A0 true IL141586A0 (en) | 2002-03-10 |
Family
ID=22268937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14158699A IL141586A0 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptide and uses thereof |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1105420A1 (pt) |
JP (2) | JP4528443B2 (pt) |
KR (1) | KR20010079695A (pt) |
CN (1) | CN1324367A (pt) |
AU (1) | AU751034B2 (pt) |
BR (1) | BR9913490A (pt) |
CA (1) | CA2341810A1 (pt) |
CZ (1) | CZ2001655A3 (pt) |
HU (1) | HUP0103265A3 (pt) |
IL (1) | IL141586A0 (pt) |
PL (1) | PL204359B1 (pt) |
WO (1) | WO2000012553A1 (pt) |
ZA (1) | ZA200102489B (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
BR9913490A (pt) * | 1998-08-28 | 2001-09-25 | Myelos Corp | Prosaposina cìclicos e seus usos |
AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
US9271932B2 (en) | 2006-04-28 | 2016-03-01 | Children's Hospital Medical Center | Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems |
CA2666953A1 (en) * | 2006-10-20 | 2008-05-02 | Children's Hospital Medical Center | Spontaneous forming ellipsoidal phospholipid unilamellar vesicles |
CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
WO2016172409A1 (en) | 2015-04-23 | 2016-10-27 | The Procter & Gamble Company | Delivery of surfactant soluble anti-dandruff agent |
CA3014923C (en) | 2016-03-03 | 2021-10-19 | Sean Michael Renock | Aerosol antidandruff composition |
CN109843383A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 用于在最佳制剂空间中递送消费者期望的剂量体积、表面活性剂量和头皮健康剂量的泡沫剂型 |
CN109862944A (zh) | 2016-10-21 | 2019-06-07 | 宝洁公司 | 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型 |
WO2018075836A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
EP3528774A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam designating hair volume benefits |
WO2018075846A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam designating hair conditioning benefits |
JP6952768B2 (ja) | 2016-10-21 | 2021-10-20 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 低粘度であり粘度低減剤を含む、安定なコンパクトシャンプー製品 |
US10653590B2 (en) | 2016-10-21 | 2020-05-19 | The Procter And Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits comprising an anionic/zwitterionic surfactant mixture |
US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
US20190105246A1 (en) | 2017-10-10 | 2019-04-11 | The Procter & Gamble Company | Sulfate free personal cleansing composition comprising low inorganic salt |
WO2019074988A1 (en) | 2017-10-10 | 2019-04-18 | The Procter & Gamble Company | METHOD OF TREATING HAIR OR SKIN WITH PERSONAL FOAM COMPOSITION IN THE FORM OF FOAM |
JP6945746B2 (ja) | 2017-10-10 | 2021-10-06 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | サルフェートフリーの界面活性剤を含有するコンパクトなシャンプー組成物 |
MX2020003318A (es) | 2017-10-10 | 2021-12-06 | Procter & Gamble | Composición de champú compacta con surfactantes aniónicos a base de aminoácidos y polímeros catiónicos. |
US10912732B2 (en) | 2017-12-20 | 2021-02-09 | The Procter And Gamble Company | Clear shampoo composition containing silicone polymers |
MX2020014144A (es) | 2018-06-29 | 2021-03-25 | Procter & Gamble | Composicion anticaspa en aerosol con bajo contenido de surfactante. |
MX2022005533A (es) | 2019-12-06 | 2022-06-08 | Procter & Gamble | Composicion libre de sulfato con deposito mejorado del activo para el cuero cabelludo. |
JP7481470B2 (ja) | 2020-02-27 | 2024-05-10 | ザ プロクター アンド ギャンブル カンパニー | 有効性及び美観が強化された硫黄含有フケ防止組成物 |
JP2023549517A (ja) | 2020-12-04 | 2023-11-27 | ザ プロクター アンド ギャンブル カンパニー | 悪臭低減物質を含むヘアケア組成物 |
US11771635B2 (en) | 2021-05-14 | 2023-10-03 | The Procter & Gamble Company | Shampoo composition |
US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
BR9913490A (pt) * | 1998-08-28 | 2001-09-25 | Myelos Corp | Prosaposina cìclicos e seus usos |
-
1999
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Application Discontinuation
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 EP EP99943903A patent/EP1105420A1/en not_active Withdrawn
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 CA CA002341810A patent/CA2341810A1/en not_active Abandoned
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/en not_active Application Discontinuation
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20010079695A (ko) | 2001-08-22 |
JP4528443B2 (ja) | 2010-08-18 |
ZA200102489B (en) | 2002-06-04 |
JP2002523518A (ja) | 2002-07-30 |
PL204359B1 (pl) | 2010-01-29 |
PL346346A1 (en) | 2002-02-11 |
EP1105420A1 (en) | 2001-06-13 |
HUP0103265A3 (en) | 2002-09-30 |
BR9913490A (pt) | 2001-09-25 |
AU751034B2 (en) | 2002-08-08 |
WO2000012553A1 (en) | 2000-03-09 |
HUP0103265A2 (hu) | 2002-02-28 |
CA2341810A1 (en) | 2000-03-09 |
CN1324367A (zh) | 2001-11-28 |
CZ2001655A3 (cs) | 2001-11-14 |
AU5690599A (en) | 2000-03-21 |
JP2010150272A (ja) | 2010-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL141586A0 (en) | Cyclic prosaposin-derived peptide and uses thereof | |
PL348648A1 (en) | Cyclic tetrapeptide compound and use thereof | |
EP1064022A4 (en) | HLA BINDING PEPTIDES AND THEIR APPLICATIONS | |
HUP0102535A3 (en) | Cd19xcd3 specific polypeptides and uses thereof | |
IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
GB9806806D0 (en) | Peptides and uses thereof | |
EP1056465A4 (en) | ANTIMICROBIAL PEPTIDES AND DERIVATIVE METAPEPTIDES | |
IL131707A0 (en) | Acetylcholinesterase-derived peptides and uses thereof | |
IL125908A (en) | Peptides and pharmaceutical compositions comprising same | |
HK1046925A1 (zh) | Mage-a12抗原肽及其用途 | |
EP0970965A4 (en) | CYCLIC PEPTIDES AND MEDICAL USE THEREOF | |
GB9918155D0 (en) | Proteins and peptides | |
IL125262A0 (en) | Synthetic peptides and pharmaceutical compositions comprising them | |
GB9714276D0 (en) | Peptides and related compounds | |
EP1080185A4 (en) | BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF. | |
GR3035848T3 (en) | Cyclic peptide derivatives | |
EP0998578A4 (en) | SEL-10 AND USES OF SEL-10 | |
GB9917165D0 (en) | Polypeptides polynuclcotides and uses thereof | |
PL341293A1 (en) | Beta-lypothropin and application thereof | |
SG74707A1 (en) | Cyclic bis-phosphites and compositions | |
EP1132472A4 (en) | NEW PROTEIN AND ITS APPLICATION | |
EP1067140A4 (en) | NEW HEMOLYTICALLY ACTIVE PROTEINS AND GENES ENCODING THEM | |
EP1139972A4 (en) | DIHYDROPYRIMIDINES AND THEIR USES | |
EP1066051A4 (en) | SCIELLIN AND ITS USE | |
GB9815088D0 (en) | Peptide and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |